Aniracetam
Fat-soluble racetam. Positive AMPA modulator with stronger anxiolytic + mood-lifting profile than piracetam.
This compound sits in research-grey territory. The caveats below carry more weight than for FDA-approved entries — read them.
1-(4-methoxybenzoyl)-2-pyrrolidinone. The fat-soluble structure means it crosses BBB faster than piracetam and enables mood/anxiolytic effects piracetam lacks. AMPA-receptor positive modulation reduces receptor desensitization. Italian-developed (1979) Roche compound. Short half-life (1-2.5 hr) means split-dose protocols are the norm. Active metabolites (anisic acid + anisoyl-GABA) extend the effective window.
Distilled themes from named communities — Reddit threads, forums, creator commentary. Not direct quotes; not clinical evidence. Useful for calibrating expectations against what real self-experimenters report.
Cohort consensus: subjectively warmer than piracetam — mood + verbal-fluency lift more noticeable than raw cognitive performance. Stacks well with caffeine + L-theanine.
Choline pairing reduces headache risk same as piracetam. Mild GI upset at high doses. Anxiety paradoxically worsens in some sensitive users — start at 750 mg before titrating. Stack with phenibut amplifies GABAergic burden — not recommended.
External links to PubMed searches, ClinicalTrials.gov, and FDA materials. We do not host papers — we point at canonical sources.
Not FDA-approved in US — same gray zone as piracetam. Prescription (Draganon, Sarpul) in some EU countries; OTC in LATAM.